参考文献/References:
[1]Thomas MN,Kalnins A,Andrassy M,et al.SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy[J].Transpl Int,2015,28(12):1426-1435.[2]Zhang Y,Zhang H,Lin S,et al.SDF-1/CXCR7 Chemokine Signaling is Induced in the Peri-Infarct Regions in Patients with Ischemic Stroke[J].Aging Dis,2018,9(2):287-295.[3]Cheng X,Wang H,Zhang X,et al.The Role of SDF-1/CXCR4/CXCR7 in Neuronal Regeneration after Cerebral Ischemia[J].Front Neurosci,2017(11):590.[4]Pozzobon T,Goldoni G,Viola A,et al.CXCR4 signaling in health and disease[J].Immunol Lett,2016(177):6-15.[5]Nagasawa T.CXCL12/SDF-1 and CXCR4[J].Front Immunol,2015(6):301.[6]Nazari A,Khorramdelazad H,Hassanshahi G.Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer[J].Int J Clin Oncol,2017,22(6):991-1000.[7]Banisadr G,Podojil JR,Miller SD,et al.Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions[J].J Neuroimmune Pharmacol,2016,11(1):26-35.[8]Qiao N,Wang L,Wang T,et al.Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells[J].Tumour Biol,2016,37(6):8169-8179. [9]Ding Q,Sun J,Xie W,et al.Stemona alkaloids suppress the positive feedback loop between M2 polarization and fibroblast differentiation by inhibiting JAK2/STAT3 pathway in fibroblasts and CXCR4/PI3K/AKT1 pathway in macrophages[J].Int Immunopharmacol,2019(72):385-394.[10]Hitchinson B,Eby JM,Gao X,et al.Biased antagonism of CXCR4 avoids antagonist tolerance[J].Sci Signal,2018,11(552):eaat2214.[11]Wu KJ,Yu SJ,Shia KS,et al.A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain[J].Cell Transplant,2017,26(4):571-583.[12]Xu D,Li R,Wu J,et al.Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway[J].Curr Top Med Chem,2016,16(13):1441-1451.[13]Puchert M,Engele J.The peculiarities of the SDF-1/CXCL12 system:in some cells,CXCR4 and CXCR7 sing solos,in others,they sing duets[J].Cell Tissue Res,2014,355(2):239-253.[14]Feng YF,Guo H,Yuan F,et al.Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell[J].PLoS One,2015,10(8):e0136175.[15]Zhu Y,Murakami F.Chemokine CXCL12 and its receptors in the developing central nervous system:emerging themes and future perspectives[J].Dev Neurobiol,2012,72(10):1349-1362.[16]Sánchez-Alcaniz JA,Haege S,Mueller W,et al.Cxcr7 controls neuronal migration by regulating chemokine responsiveness[J].Neuron,2011,69(1):77-90.[17]Uto-Konomi A,McKibben B,Wirtz J,et al.CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4[J].Biochem Biophys Res Commun,2013,431(4):772-776.[18]Ullah TR.The role of CXCR4 in multiple myeloma:Cells’ journey from bone marrow to beyond[J].J Bone Oncol,2019(17):100253.[19]Levoye A,Balabanian K,Baleux F,et al.CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling[J].Blood,2009,113(24):6085-6093.[20]Décaillot FM,Kazmi MA,Lin Y,et al.CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration[J].J Biol Chem,2011,286(37):32188-32197.[21]Borlongan CV,Glover LE,Tajiri N,et al.The great migration of bone marrow-derived stem cells toward the ischemic brain:therapeutic implications for stroke and other neurological disorders[J].Prog Neurobiol,2011,95(2):213-228. [22]Harten SK,Ashcroft M,Maxwell PH.Prolyl hydroxylase domain inhibitors:a route to HIF activation and neuroprotection[J].Antioxid Redox Signal,2010,12(4):459-480.[23]Chang YC,Shyu WC,Lin SZ,et al.Regenerative therapy for stroke[J].Cell Transplant,2007,16(2):171-181.[24]Williams JL,Holman DW,Klein RS.Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers[J].Front Cell Neurosci,2014(8):154. [25]Chen Q,Zhang M,Li Y,et al.CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4[J].Stem Cells,2015,33(8):2574-2585. [26]Merino JJ,Bellver-Landete V,Oset-Gasque MJ,et al.CXCR4/CXCR7 molecular involvement in neuronal and neural progenitor migration: focus in CNS repair[J].J Cell Physiol,2015,230(1):27-42. [27]Liu L,Chen JX,Zhang XW,et al.Chemokine receptor 7 overexpression promotes mesenchymal stem cell migration and proliferation via secreting Chemokine ligand 12[J].Sci Rep,2018,8(1):204. [28]Bogoslovsky T,Spatz M,Chaudhry A,et al.Stromal-derived factor-1[alpha]correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients[J].Stroke,2011,42(3):618-625.[29]Keshavarz S,Nassiri SM,Siavashi V,et al.Regulation of plasticity and biological features of endothelial progenitor cells by MSC-derived SDF-1[J].Biochim Biophys Acta Mol Cell Res,2019,1866(2):296-304.[30]Song C,Xu W,Zhang X,et al.CXCR4 antagonist AMD3100 suppresses the long-term abnormal structural changes of newborn neurons in the intraventricular kainic acid model of epilepsy[J].Mol Neurol Biol,2015(53):1518-1532.[31]Zhang XQ,Mu JW,Wang HB,et al.Increased protein expression levels of pCREB, BDNF and SDF-1/CXCR4 in the hippocampus may be associated with enhanced neurogenesis induced by environmental enrichment[J].Mol Med Rep,2016(14):2231-2237.[32]Sun X,Zhou Z,Liu T,et al.Fluoxetine enhances neurogenesis in aged rats with cortical infarcts,but this is not reflected in a behavioral recovery[J].J Mol Neurosci,2016(58):233-242. [33]Sun Y,Cheng X,Wang H,et al.dl-3-n-butylphthalide promotes neuroplasticity and motor recovery in stroke rats[J].Behav Brain Res,2017(329):67-74.[34]Xu W,Mu X,Wang H,et al.Chloride co-transporter NKCC1 inhibitor bumetanide enhances neurogenesis and behavioral recovery in rats after experimental stroke[J].Mol Neurobiol,2017(54):2406-2414.[35]Dong BC,Li MX,Wang XY,et al.Effects of CXCR7-neutralizing antibody on neurogenesis in the hippocampal dentate gyrus and cognitive function in the chronic phase of cerebral ischemia[J].Neural Regen Res,2020,15(6):1079-1085. [36]Wang Y,Xu P,Qiu L,et al.CXCR7 participates in CXCL12-mediated cell cycle and proliferation regulation in mouse neural progenitor cells[J].Curr Mol Med,2016(16):738-746.
相似文献/References:
[1]曾 意,汤永红,张 平.CYP2C19基因多态性与复发性缺血性卒中关系的研究[J].医学信息,2022,35(11):22.[doi:10.3969/j.issn.1006-1959.2022.11.007]
ZENG Yi,TANG Yong-hong,ZHANG Ping.Study on Correlation Between CYP2C19 Gene Polymorphism and Recurrent Ischemic Stroke[J].Medical Information,2022,35(11):22.[doi:10.3969/j.issn.1006-1959.2022.11.007]
[2]杨 艳,王思迅,宋春江.脑白质疏松对急性缺血性卒中患者认知功能的影响[J].医学信息,2019,32(01):88.[doi:10.3969/j.issn.1006-1959.2019.01.027]
YANG Yan,WANG Si-xun,SONG Chun-jiang.Effect of Leukoaraiosis on Cognitive Function in Patients with Acute Ischemic Stroke[J].Medical Information,2019,32(11):88.[doi:10.3969/j.issn.1006-1959.2019.01.027]
[3]郑 璇,孙熙罡.“调神益咽”针刺法配合康复训练治疗缺血性中风后吞咽障碍的疗效观察[J].医学信息,2019,32(10):156.[doi:10.3969/j.issn.1006-1959.2019.10.052]
ZHENG Xuan,SUN Xi-gang.Therapeutic Effect of"Tiaoshen Yiyan"Acupuncture Combined with Rehabilitation Training on Dysphagia after Ischemic Stroke[J].Medical Information,2019,32(11):156.[doi:10.3969/j.issn.1006-1959.2019.10.052]
[4]冯莹印,高 晓,宋金玉,等.高脂血症与颈动脉粥样硬化斑块的关系研究[J].医学信息,2022,35(13):89.[doi:10.3969/j.issn.1006-1959.2022.13.019]
FENG Ying-yin,GAO Xiao,SONG Jin-yu,et al.Relationship Between Hyperlipidemia and Carotid Atherosclerotic Plaque[J].Medical Information,2022,35(11):89.[doi:10.3969/j.issn.1006-1959.2022.13.019]
[5]邵景萍.米非司酮周期疗法与孕激素治疗围绝经期异常子宫出血的临床效果[J].医学信息,2022,35(08):153.[doi:10.3969/j.issn.1006-1959.2022.08.039]
SHAO Jing-ping.The Clinical Effect of Mifepristone Cycle Therapy and Progesterone in the Treatment of Perimenopausal Abnormal Uterine Bleeding[J].Medical Information,2022,35(11):153.[doi:10.3969/j.issn.1006-1959.2022.08.039]
[6]万仁娟.脑心健康管理师在缺血性卒中患者全程健康管理中的作用研究[J].医学信息,2023,36(11):153.[doi:10.3969/j.issn.1006-1959.2023.11.032]
WAN Ren-juan.Study on the Role of Brain-heart Health Manager in the Whole-course Health Management of Patients with Ischemic Stroke[J].Medical Information,2023,36(11):153.[doi:10.3969/j.issn.1006-1959.2023.11.032]